Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Surgery Partners, Inc. Director's Dealing 2023

Mar 6, 2023

31430_dirs_2023-03-06_b5865042-da81-4928-b82c-8b280328f045.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Surgery Partners, Inc. (SGRY)
CIK: 0001638833
Period of Report: 2023-01-31

Reporting Person: Burkhalter Danielle (Chief Human Resources Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-01-31 Common Stock A 740 $54.03 Acquired 13233 Direct
2023-02-13 Common Stock S 123 $33.88 Disposed 13110 Direct
2023-01-31 Common Stock S 757 $33.55 Disposed 12353 Direct
2023-03-02 Common Stock A 15216 $32.86 Acquired 27569 Direct
2023-03-02 Common Stock A 3804 $32.86 Acquired 31373 Direct

Footnotes

F1: Shares issued based on 2022 performance under performance stock unit awards granted to the Reporting Person on March 11, 2022. Shares will vest in two equal annual installments on each of the first two anniversaries of January 31, 2023.

F2: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 10, 2023.

F3: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2023.

F4: Shares will all vest on the third anniversary of March 2, 2023.

F5: Shares will vest in three equal annual installments of each of the first three anniversaries of March 2, 2023.